The Ovarian Cancer Research Program (OCRP) is a cutting-edge program housed within the Department of Defense. Despite a history of successful breakthroughs, the program has long been drastically underfunded.
The House and Senate are currently working to determine funding levels for programs in Fiscal Year 2021. Urge your Members of Congress to support full funding for the Ovarian Cancer Research Program (OCRP)!
As you may remember, last year ovarian cancer advocates were successful in increasing funding for OCRP from $20 million to $35 million.This was a huge win, that YOUR voice made possible. The critical boost in funding was long overdue and has allowed cutting-edge research to move forward.